Member Beup posted in today's feed about food vs Jak2. In checking it out I came across this one. It's regarding the supplement Resveratrol and is from from 2015 and has been posted before by Member "Hidden".
<<Resveratrol selectively induces apoptosis in malignant cells with the JAK2V617F mutation by inhibiting the JAK2 pathway.>>
semanticscholar.org/paper/R...
Their conclusion says << Moreover, resveratrol synergized with the selective JAK2 inhibitor ruxolitinib, eliminating tumor cells with the JAK2 mutation.>>
Who here wants their tumor cells "eliminated"?
It's behind a paywall and not amateur friendly. The only Fig I can make anything of is here. The black is inactive solvent DMSO. RVT is Resveratrol. Resver and Rux are of similar effect reducing proliferation. I can't find any figures supporting their radical claim for the combo. But it leads to the question combining it with INF.
There is a study of Resv with INF for Hep B, no publication yet that I can find. Should at least show safety results.
clinicaltrials.gov/ct2/hist...
Resveratrol is easily available. But in: ncbi.nlm.nih.gov/pmc/articl...
<<Nonetheless, resveratrol application is still being a major challenge for pharmaceutical industry, due to its poor solubility and bioavailability, as well as adverse effects. In this sense, this review summarized current data on resveratrol pharmacological effects.>>
It looks like it can be toxic in very high doses.